| KNTE Stock Yearly Return 2022 Table | ||||||||||||||||||||||||||||||
KNTE average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare KNTE average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| KNTE Share Performance |
| KNTE Stock Yearly Return 2022 Chart | |||
Also see: • KNTE YTD return • KNTE average annual return 10 years | |||
| About Kinnate Biopharma Inc |
| Kinnate is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for genomically defined cancers. Co.'s focus is on three patient populations: those with cancers that harbor known oncogenic drivers with no available targeted therapies; those with genomically well-characterized tumors that have resistance to available treatments; and those whose tumors have acquired resistance over the course of therapy to available treatments. Co.'s product candidates are KIN002787, which is for the treatment of patients with lung cancer, melanoma and other solid tumors; and KIN-3248, which is targeting cancer-associated alterations in FGFR2. The KNTE stock yearly return is shown above.
The yearly return on the KNTE stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2022 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the KNTE annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| KNTE Current Stock Quote |
 Free KNTE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Kinnate Biopharma (KNTE) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
KOD Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!